FDA aims to boost access to life-saving overdose drug Naloxone
SAN DIEGO (KUSI) – The food and drug administration put out guidance Sept. 22 aimed at boosting access to the lifesaving overdose drug Naloxone.
The change is meant to help harm-reduction programs more easily access the opioid antidote by making them exempt from certain FDA rules.
The American Medical Association said the new guidance provides more clarity for those organizations to buy Naloxone for community distribution.
The AMA lauded the work of harm reduction programs and expressed gratitude for the FDA recognizing the importance of the work.